ALCAM and triple-negative breast carcinoma: Work by Fernandez et al. and Ferragut et al. [17,18] has shown that ALCAM, via its glycosylation, works in orchestration with Galectin-8, a portraited internal ligand for ALCAM, in triple-negative breast cancer cells [18].